Transcatheter aortic valve implantation in a young heart transplant recipient crossing the traditional boundaries

Transcatheter aortic valve implantation (TAVI) is an established therapeutic alternative to surgical aortic valve replacement (SAVR) in high-risk or inoperable patients with symptomatic aortic valve stenosis. Hitherto, TAVI is not recommended in young and low-intermediate risk patients. However, TAVI may also serve as an alternative to SAVR in selected young patients, e.g., patients who have previously undergone multiple cardiac surgery procedures. We report a case of trans-femoral TAVI in a 25-year-old heart transplant (HTx) recipient with prior surgery for congenital heart disease.

Medienart:

E-Artikel

Erscheinungsjahr:

2016

Erschienen:

2016

Enthalten in:

Zur Gesamtaufnahme - volume:8

Enthalten in:

Journal of thoracic disease - 8(2016), 8 vom: 26. Aug., Seite E711-4

Sprache:

Englisch

Beteiligte Personen:

Ahmad, Khalil [VerfasserIn]
Terkelsen, Christian Juhl [VerfasserIn]
Terp, Kim Allan [VerfasserIn]
Mathiassen, Ole Norling [VerfasserIn]
Nørgaard, Bjarne Linde [VerfasserIn]
Andersen, Henning Rud [VerfasserIn]
Poulsen, Steen Hvitfeldt [VerfasserIn]

Links:

Volltext

Themen:

Aorta stenosis
Case Reports
Heart transplant (HTx)
Transcatheter aortic valve implantation (TAVI)

Anmerkungen:

Date Completed 13.09.2016

Date Revised 10.03.2022

published: Print

Citation Status PubMed-not-MEDLINE

doi:

10.21037/jtd.2016.07.61

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM264281837